open access
Sleep-related breathing disorders in patients with Prader-Willi syndrome depending on the period of growth hormone treatment
open access
Abstract
Abstract
Keywords
sleep-related breathing disorders, Prader-Willi Syndrome, growth hormone treatment
Title
Sleep-related breathing disorders in patients with Prader-Willi syndrome depending on the period of growth hormone treatment
Journal
Issue
Article type
Original paper
Pages
676-681
Published online
2017-09-25
Page views
1670
Article views/downloads
1425
DOI
Pubmed
Bibliographic record
Endokrynol Pol 2017;68(6):676-681.
Keywords
sleep-related breathing disorders
Prader-Willi Syndrome
growth hormone treatment
Authors
Agnieszka Lecka-Ambroziak
Małgorzata Jędrzejczak
Marta Wysocka-Mincewicz
Mieczysław Szalecki
- Goldstone AP, Holland AJ, Hauffa BP, et al. speakers contributors at the Second Expert Meeting of the Comprehensive Care of Patients with PWS. Recommendations for the diagnosis and management of Prader-Willi syndrome. J Clin Endocrinol Metab. 2008; 93(11): 4183–4197.
- Menendez AA. Abnormal ventilatory responses in patients with Prader-Willi syndrome. Eur J Pediatr. 1999; 158(11): 941–942.
- Eiholzer U. Deaths in Children with Prader-Willi Syndrome. Horm Res Paediatr. 2005; 63(1): 33–39.
- Bakker B, Maneatis T, Lippe B. Sudden Death in Prader-Willi Syndrome: Brief Review of Five Additional Cases. Horm Res. 2007; 67: 203–204.
- Haqq AM, Stadler DD, Jackson RH, et al. Effects of growth hormone on pulmonary function, sleep quality, behavior, cognition, growth velocity, body composition, and resting energy expenditure in Prader-Willi syndrome. J Clin Endocrinol Metab. 2003; 88(5): 2206–2212.
- Festen DAM, de Weerd AW, van den Bossche RAS, et al. Sleep-related breathing disorders in prepubertal children with Prader-Willi syndrome and effects of growth hormone treatment. J Clin Endocrinol Metab. 2006; 91(12): 4911–4915.
- de Lind van Wijngaarden RFA, Siemensma EPC, Festen DAM, et al. Efficacy and safety of long-term continuous growth hormone treatment in children with Prader-Willi syndrome. J Clin Endocrinol Metab. 2009; 94(11): 4205–4215.
- Carrel AL, Myers SE, Whitman BY, et al. Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome. J Clin Endocrinol Metab. 2010; 95(3): 1131–1136.
- Miller J, Silverstein J, Shuster J, et al. Short-term effects of growth hormone on sleep abnormalities in Prader-Willi syndrome. J Clin Endocrinol Metab. 2006; 91(2): 413–417.
- Nixon GM, Rodda CP, Davey MJ. Longitudinal association between growth hormone therapy and obstructive sleep apnea in a child with Prader-Willi syndrome. J Clin Endocrinol Metab. 2011; 96(1): 29–33.
- Llombart M, Chiner E, Gómez-Merino E, et al. Sleep Apnea-Hypopnea Syndrome in a Pediatric Population: Differences Between Children With Tonsillar Hypertrophy and Those With Concomitant Disease. Arch Bronconeumol. 2007; 43(12): 655–661.
- Iber C, Ancoli-Israel S, Chesson JrA, et al. The AASM Manual for the scoring of sleep and associated events: rules, terminology and technical specifications, 1st ed. Westchester, Illinois. : 2007.
- Wise MS, Nicholas CD, Grigg-Damberger MM, et al. Respiratory indications for polysomnography in children: an evidence-based review. Sleep. 2011; 34: 398A–398AW.
- Aurora RN, Zak RS, Karippot A, et al. American Academy of Sleep Medicine. Practice parameters for the respiratory indications for polysomnography in children. Sleep. 2011; 34(3): 379–388.
- Marcus CL, Brooks LJ, Draper KA, et al. American Academy of Pediatrics, American Academy of Pediatrics. Diagnosis and management of childhood obstructive sleep apnea syndrome. Pediatrics. 2012; 130(3): 576–584.
- Uliel S, Tauman R, Greenfeld M, et al. Normal polysomnographic respiratory values in children and adolescents. Chest. 2004; 125(3): 872–878.
- Fietze I, Dingli K, Diefenbach K, et al. Night-to-night variation of the oxygen desaturation index in sleep apnoea syndrome. Eur Respir J. 2004; 24(6): 987–993.
- Scholle S, Wiater A, Scholle HC. Normative values of polysomnographic parameters in childhood and adolescence: cardiorespiratory parameters. Sleep Med. 2011; 12(10): 988–996.
- Cohen M, Hamilton J, Narang I. Clinically important age-related differences in sleep related disordered breathing in infants and children with Prader-Willi Syndrome. PLoS One. 2014; 9(6): e101012.
- De Cock VC, Diene G, Molinas C, et al. Efficacy of modafinil on excessive daytime sleepiness in Prader-Willi syndrome. Am J Med Genet A. 2011; 155A(7): 1552–1557.
- Muzumdar H, Arens R. Diagnostic issues in pediatric obstructive sleep apnea. Proc Am Thorac Soc. 2008; 5(2): 263–273.
- Palczewska I, Niedźwiecka Z. Somatic development indices in children and youth of Warsaw. Med Wieku Rozw. 2001; 5: 1–118.
- Lin HY, Lin SP, Lin CC, et al. Polysomnographic characteristics in patients with Prader-Willi syndrome. Pediatr Pulmonol. 2007; 42(10): 881–887.
- Williams K, Scheimann A, Sutton V, et al. Sleepiness and sleep disordered breathing in Prader-Willi syndrome: relationship to genotype, growth hormone therapy, and body composition. J Clin Sleep Med. 2008; 4(2): 111–118.
- Deal CL, Tony M, Hoybye C, et al. Consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome. J Clin Endocrinol Metab. 2013; 98: E1072–E1087.
- Lindgren AC. increases CO2 response, ventilation and central inspiratory drive in children with Prader-Willi syndrome. Eur J Pediatr. 1999; 158: 936–940.
- Katz-Salamon M, Lindgren AC, Cohen G. The effect of growth hormone on sleep-related cardio-respiratory control. Acta Ped. 2012; 101: 643–648.